Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith T Flaherty

Showing results (51-60 of 418) with videos related to

Pageof 42
Sort By:
Pigment Cell & Melanoma Research|July 22, 2009
Preclinical and clinical development of targeted therapy in melanoma: attention to scheduleKeith T Flaherty, Keiran S M Smalley
Molecular Aspects of Medicine|February 24, 2010
Molecular therapeutic approaches to melanomaZhenyu Ji, Keith T Flaherty, Hensin Tsao
Nature Reviews. Drug Discovery|November 1, 2011
VemurafenibKeith T Flaherty, Uma Yasothan, Peter Kirkpatrick
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2013
BRAF in melanoma: current strategies and future directionsApril K S Salama, Keith T Flaherty
Molecular Oncology|March 12, 2011
Biological challenges of BRAF inhibitor therapyIgor Puzanov, Patrick Burnett, Keith T Flaherty
Trends in Molecular Medicine|October 4, 2011
Targeting the RAS pathway in melanomaZhenyu Ji, Keith T Flaherty, Hensin Tsao
Nature Reviews. Clinical Oncology|April 11, 2019
Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathwaysXue Bai, David E Fisher, Keith T Flaherty
Hematology/Oncology Clinics of North America|July 6, 2024
Targeted Therapy Innovations for MelanomaDahiana Amarillo, Keith T Flaherty, Ryan J Sullivan
Seminars in Cutaneous Medicine and Surgery|August 3, 2014
Current status and future directions of molecularly targeted therapies and immunotherapies for melanomaDavid M Miller, Keith T Flaherty, Hensin Tsao
Journal of the American Academy of Dermatology|February 19, 2014
Commentary: Molecular testing in melanomaDavid M Miller, Keith T Flaherty, Hensin Tsao
Pageof 42

Showing results (51-60 of 418) with videos related to

Sort By:
Pageof 42
Pigment Cell & Melanoma Research|July 22, 2009
Preclinical and clinical development of targeted therapy in melanoma: attention to scheduleKeith T Flaherty, Keiran S M Smalley
Molecular Aspects of Medicine|February 24, 2010
Molecular therapeutic approaches to melanomaZhenyu Ji, Keith T Flaherty, Hensin Tsao
Nature Reviews. Drug Discovery|November 1, 2011
VemurafenibKeith T Flaherty, Uma Yasothan, Peter Kirkpatrick
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2013
BRAF in melanoma: current strategies and future directionsApril K S Salama, Keith T Flaherty
Molecular Oncology|March 12, 2011
Biological challenges of BRAF inhibitor therapyIgor Puzanov, Patrick Burnett, Keith T Flaherty
Trends in Molecular Medicine|October 4, 2011
Targeting the RAS pathway in melanomaZhenyu Ji, Keith T Flaherty, Hensin Tsao
Nature Reviews. Clinical Oncology|April 11, 2019
Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathwaysXue Bai, David E Fisher, Keith T Flaherty
Hematology/Oncology Clinics of North America|July 6, 2024
Targeted Therapy Innovations for MelanomaDahiana Amarillo, Keith T Flaherty, Ryan J Sullivan
Seminars in Cutaneous Medicine and Surgery|August 3, 2014
Current status and future directions of molecularly targeted therapies and immunotherapies for melanomaDavid M Miller, Keith T Flaherty, Hensin Tsao
Journal of the American Academy of Dermatology|February 19, 2014
Commentary: Molecular testing in melanomaDavid M Miller, Keith T Flaherty, Hensin Tsao
Pageof 42